Pharma IQ Members

Market Access

Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.

221 results
of 21
Contributor: Chanice Henry
Posted: 19/09/2017
Chan
As the globe’s health systems groan under financial pressure, analysts have identified large differences in the amounts European patients pay for generics. Full Content »
Contributor: Katie Sadler
Posted: 11/09/2017
Katie Sadler
Study reveals UK pharmacy scheme will provide long-term savings for National Health Service (NHS) England Full Content »
Contributor: Pharma IQ News
Posted: 06/09/2017
Pharma IQ News
As many pharma manufacturers are rushing to discover the next blockbuster treatment in personalized medicine, the US FDA has approved Kymriah – the first chimeric antigen receptor T cell (CAR-T) therapy. Full Content »
Contributor: Pharma IQ
Posted: 05/09/2017
Pharma IQ
As pharma spend continues to climb, so does public scrutiny on drug pricing. Once again, medicine manufacturers are spurred to strike a fair solution to balance raging its R&D appetites with affordable access to treatments for patients Full Content »
Contributor: Dane Hartung
Posted: 29/08/2017
Dane TN
Dane Hartung, Director Marketing and Access, Fougera Pharmaceuticals shares best practices for determining if and when you should implement a new Commercial Patient Access Program. Dane also discusses how you should go about ensuring your patient access program is ethical, compliant and effectively differentiates your product. Full Content »
Contributor: Ash Rishi
Posted: 14/08/2017
Ash Rishi
Customers enjoy interacting with brands on social media when it gives them great results: special offers, the chance to win prize draws, or a swift and generous response to a complaint. But, how can this experience - an increasingly important feature of consumer retail - be translated to the more tightly-regulated field of pharmaceuticals? Full Content »
Contributor: Pharma IQ
Posted: 11/07/2017
Pharma IQ
Despite some in the market choosing to shut down certain departments, many in the pharma industry are embarking on expansions. Ireland is expected to see a lot of growth Full Content »
Contributor: Pharma IQ News
Posted: 20/06/2017
Pharma IQ News
The Reputation Institute has revealed the top 10 most reputable pharma companies as voted by the general public. In a surprising result, AstraZeneca and GSK both failed to make the top 10. Full Content »
Contributor: Chanice Henry
Posted: 13/06/2017
Chan
Astrazeneca and its biologics arm, Medimmune, advance in the R&D race as three new oncology drug candidates see promising developments Full Content »
Contributor: Pharma IQ
Posted: 09/05/2017
Pharma IQ
Pharma IQ explores the power behind medicine optimisation and the trends emerging in the pharma and healthcare market recently. Full Content »
Contributor: Ash Rishi
Posted: 18/04/2017
Ash Rishi
Patient education is an important factor in disease self-management, and when handled properly it has been found to have a significant, positive impact on improving patient outcomes. Full Content »
221 results
of 21